These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 18793116

  • 21. Urotensin II and cardiovascular diseases.
    Thanassoulis G, Huyhn T, Giaid A.
    Peptides; 2004 Oct; 25(10):1789-94. PubMed ID: 15476947
    [Abstract] [Full Text] [Related]

  • 22. Regulation of the inducible nitric oxide synthase and sodium pump in type 1 diabetes.
    Zakula Z, Koricanac G, Putnikovic B, Markovic L, Isenovic ER.
    Med Hypotheses; 2007 Oct; 69(2):302-6. PubMed ID: 17289286
    [Abstract] [Full Text] [Related]

  • 23. Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis.
    Li Y, Wu H, Khardori R, Song YH, Lu YW, Geng YJ.
    Biochem Biophys Res Commun; 2009 Jun 26; 384(2):259-64. PubMed ID: 19406106
    [Abstract] [Full Text] [Related]

  • 24. Atherosclerosis in diabetes and insulin resistance.
    Reusch JE, Draznin BB.
    Diabetes Obes Metab; 2007 Jul 26; 9(4):455-63. PubMed ID: 17587387
    [Abstract] [Full Text] [Related]

  • 25. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N, Küchler J, Endl E, Koch A, Czerwitzki J, Wurst P, Metzger D, Schulte JH, Holst MI, Heukamp LC, Larsson O, Tanaka S, Kawai A, Wardelmann E, Buettner R, Pietsch T, Hartmann W.
    J Pathol; 2008 Dec 26; 216(4):428-39. PubMed ID: 18855347
    [Abstract] [Full Text] [Related]

  • 26. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP, Thomas H, Marks C, Green M, Fan Z, Modjtahedi H.
    Int J Oncol; 2008 Nov 26; 33(5):1107-13. PubMed ID: 18949375
    [Abstract] [Full Text] [Related]

  • 27. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Nov 26; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The role of IGF-system in vascular insulin resistance.
    Arnqvist HJ.
    Horm Metab Res; 2008 Sep 26; 40(9):588-92. PubMed ID: 18792869
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.